Angiopep-Conjugated Nanoparticles for Targeted Long-Term Gene Therapy of Parkinson’s Disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiopep-Conjugated Nanoparticles for Targeted Long-Term Gene Therapy of Parkinson’s Disease
Authors
Keywords
angiopep-conjugated nanoparticles, dendrigraft poly-L-lysine, gene therapy, multiple dosing administrations, Parkinson’s disease
Journal
PHARMACEUTICAL RESEARCH
Volume 30, Issue 10, Pages 2549-2559
Publisher
Springer Nature
Online
2013-05-24
DOI
10.1007/s11095-013-1005-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene and doxorubicin co-delivery system for targeting therapy of glioma
- (2012) Shuhuan Liu et al. BIOMATERIALS
- Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson’s disease: focus on levodopa/carbidopa/entacapone
- (2012) Heinz Reichmann et al. Expert Review of Neurotherapeutics
- Neuroprotection by GDNF in the ischemic brain
- (2012) Emília P. Duarte et al. GROWTH FACTORS
- Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model
- (2012) Sylvia Wagner et al. PLoS One
- Choline-Derivate-Modified Nanoparticles for Brain-Targeting Gene Delivery
- (2011) Jianfeng Li et al. ADVANCED MATERIALS
- L-Dopa Prodrugs: An Overview of Trends for Improving Parkinsons Disease Treatment
- (2011) Antonio Di Stefano et al. CURRENT PHARMACEUTICAL DESIGN
- Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration
- (2010) Rongqin Huang et al. BIOMATERIALS
- Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain
- (2010) Kun Shao et al. JOURNAL OF CONTROLLED RELEASE
- Evaluation and mechanism studies of PEGylated dendrigraft poly-L-lysines as novel gene delivery vectors
- (2010) Rongqin Huang et al. NANOTECHNOLOGY
- Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer
- (2009) Weilun Ke et al. BIOMATERIALS
- Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles
- (2009) Rongqin Huang et al. JOURNAL OF GENE MEDICINE
- Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model
- (2009) Rongqin Huang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Gene Therapy for Dopamine Replacement in Parkinsons Disease
- (2009) A. Bjorklund et al. Science Translational Medicine
- Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2
- (2008) Michel Demeule et al. JOURNAL OF NEUROCHEMISTRY
- The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain
- (2007) Rongqin Huang et al. BIOMATERIALS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now